Kestra Medical Technologies, Ltd. earnings releases KMTS

Annual Quarterly

Kestra Medical Technologies, Ltd. last reported quarterly results on Sep 14, 2026, for Q1 FY2026 (the quarter ended Jul 31, 2026): revenue of $31.0 million (+59.9% year over year) and diluted EPS of -$0.75. It usually reports 31–75 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 30, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 31–75 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Sep 14, 2026
45 days after quarter end
Q1 FY2026
ended Jul 31, 2026
31
+59.9%
-44
-70.7%
-0.75
-50.0%
Jul 14, 2026
75 days after quarter end
Q4 FY2026
ended Apr 30, 2026
29
-39
-0.67
Mar 17, 2026
45 days after quarter end
Q3 FY2026
ended Jan 31, 2026
25
-34
-0.61
Dec 1, 2025
31 days after quarter end
Q2 FY2025
ended Oct 31, 2025
23
-33
-0.64
Sep 11, 2025
42 days after quarter end
Q1 FY2025
ended Jul 31, 2025
19
-26
-0.50
Apr 14, 2025
73 days after quarter end
—
ended Jan 31, 2025
—
—
—

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
KMTS (Nasdaq)
Fiscal year ends
April 30
Incorporated in
Bermuda
Headquarters
Kirkland, WA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1877184

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.